Baxter Dextrose Injection 70% recalled for stainless steel particles
Baxter Healthcare identified stainless steel particles in certain 2000 mL bags of Dextrose Injection, USP 70%. The contamination affected 606 bags (Lot #Y495066, expiration July 31, 2027) distributed nationwide. No injuries have been reported.
From the FDA notice · Read the official notice ↗ · All Baxter recalls
What to do
- Do not use affected bags of Dextrose Injection, USP 70%, Lot #Y495066.
- Contact Baxter Healthcare or your pharmacy for guidance on safe disposal and replacement.
- Check your facility's inventory for the recalled lot number.
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Dextrose Injection, USP, 70 %, 2000 mL bags, Rx Only, Baxter Healthcare Corporation Deerfield, IL, 60016, Made in USA, NDC 00338-0719-06
- Sold in
- Nationwide
- Made for
- All ages (0 months and older)
Details
- Units affected
- 606 bags
- Illnesses reported
- None reported
- Manufactured in
- 1 Baxter Pkwy, Deerfield, IL, United States
- Classification
- Class I
- Recall number
- D-0850-2026
In the FDA's words
- Description
- Dextrose Injection, USP, 70 %, 2000 mL bags, Rx Only, Baxter Healthcare Corporation Deerfield, IL, 60016, Made in USA, NDC 00338-0719-06 Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution. Lot #: Y495066, Exp. Date July 31, 2027 Distribution: U.S. Nationwide. Affected quantity: 606 bags
- Hazard
- Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution.
More from Baxter
See all- Voalte Nurse Call software recalled for possible response delays
ModerateFDANov 13, 2026
- Baxter TruSystem 7500 surgical table recalled for unexpected drop risk
SeriousFDANov 3, 2026
- Baxter TruSystem 7000 U operating table recalled for possible unexpected drop
SeriousFDANov 3, 2026